Literature DB >> 21773853

MicroRNAs and cancer therapeutics.

Man Lung Yeung1, Kuan-Teh Jeang.   

Abstract

MicroRNAs (miRNAs) are small physiological non-coding RNAs that regulate gene expression through an RNA interference (RNAi) mechanism. The expression of miRNAs is tightly controlled both spatially and temporally. Aberrant miRNA expression has been correlated with various cancers. Recent findings suggest that some miRNAs can function as tumor suppressors or oncogenes. In model experiments, the cancer phenotype of some cells can be reverted to normal when the cells are treated with miRNA mimics or inhibitors. Here, we discuss in brief the potential utility of miRNA-based cancer therapy as well as the current limitations thwarting their useful clinical application.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21773853      PMCID: PMC3404888          DOI: 10.1007/s11095-011-0526-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  73 in total

1.  hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.

Authors:  Eran Elyakim; Einat Sitbon; Alexander Faerman; Sarit Tabak; Eve Montia; Liron Belanis; Avital Dov; Eric G Marcusson; C Frank Bennett; Ayelet Chajut; Dalia Cohen; Noga Yerushalmi
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

Review 2.  Regulation of mRNA translation and stability by microRNAs.

Authors:  Marc Robert Fabian; Nahum Sonenberg; Witold Filipowicz
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

3.  A viral microRNA functions as an orthologue of cellular miR-155.

Authors:  Eva Gottwein; Neelanjan Mukherjee; Christoph Sachse; Corina Frenzel; William H Majoros; Jen-Tsan A Chi; Ravi Braich; Muthiah Manoharan; Jürgen Soutschek; Uwe Ohler; Bryan R Cullen
Journal:  Nature       Date:  2007-12-13       Impact factor: 49.962

4.  MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis.

Authors:  Sudarshan Anand; Bharat K Majeti; Lisette M Acevedo; Eric A Murphy; Rajesh Mukthavaram; Lea Scheppke; Miller Huang; David J Shields; Jeffrey N Lindquist; Philip E Lapinski; Philip D King; Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2010-08-01       Impact factor: 53.440

5.  Expanding the microRNA targeting code: functional sites with centered pairing.

Authors:  Chanseok Shin; Jin-Wu Nam; Kyle Kai-How Farh; H Rosaria Chiang; Alena Shkumatava; David P Bartel
Journal:  Mol Cell       Date:  2010-06-25       Impact factor: 17.970

6.  Identification of small molecules that suppress microRNA function and reverse tumorigenesis.

Authors:  Koichi Watashi; Man Lung Yeung; Matthew F Starost; Ramachandra S Hosmane; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

7.  miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

Authors:  Stephanie Ma; Kwan Ho Tang; Yuen Piu Chan; Terence K Lee; Pak Shing Kwan; Antonia Castilho; Irene Ng; Kwan Man; Nathalie Wong; Ka-Fai To; Bo-Jian Zheng; Paul B S Lai; Chung Mau Lo; Kwok Wah Chan; Xin-Yuan Guan
Journal:  Cell Stem Cell       Date:  2010-12-03       Impact factor: 24.633

8.  Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

Authors:  Yunching Chen; Xiaodong Zhu; Xiaoju Zhang; Bin Liu; Leaf Huang
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

Review 9.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

10.  Silencing of mammalian genes by tetracycline-inducible shRNA expression.

Authors:  Sven Kappel; Yves Matthess; Manfred Kaufmann; Klaus Strebhardt
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

View more
  14 in total

Review 1.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

Review 2.  MicroRNAs and HIV-1: complex interactions.

Authors:  Zachary Klase; Laurent Houzet; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

Review 3.  The role of the mediators of inflammation in cancer development.

Authors:  José Veríssimo Fernandes; Ricardo Ney Oliveira Cobucci; Carlos André Nunes Jatobá; Thales Allyrio Araújo de Medeiros Fernandes; Judson Welber Veríssimo de Azevedo; Josélio Maria Galvão de Araújo
Journal:  Pathol Oncol Res       Date:  2015-03-05       Impact factor: 3.201

Review 4.  MicroRNA-21 gene and cancer.

Authors:  Yong Huang; You Bing Yang; Xiao Hui Zhang; Xue Li Yu; Zhan Bin Wang; Xiang Chao Cheng
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

Review 5.  Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Authors:  Koji Ueno; Hiroshi Hirata; Yuji Hinoda; Rajvir Dahiya
Journal:  Int J Cancer       Date:  2012-08-30       Impact factor: 7.396

6.  Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.

Authors:  Orsolya Kiss; Anna-Mária Tőkés; Sándor Spisák; Anna Szilágyi; Norbert Lippai; Borbála Székely; A Marcell Szász; Janina Kulka
Journal:  Pathol Oncol Res       Date:  2014-09-21       Impact factor: 3.201

Review 7.  Oligonucleotide conjugates for therapeutic applications.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2013-07

Review 8.  Host restriction factors in retroviral infection: promises in virus-host interaction.

Authors:  Yong-Hui Zheng; Kuan-Teh Jeang; Kenzo Tokunaga
Journal:  Retrovirology       Date:  2012-12-20       Impact factor: 4.602

9.  ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer.

Authors:  Quanlu Duan; Xingxu Wang; Wei Gong; Li Ni; Chen Chen; Xingxing He; Fuqiong Chen; Lei Yang; Peihua Wang; Dao Wen Wang
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 10.  miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.

Authors:  Volker Baumann; Johannes Winkler
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.